GMAB
Genmab A/S · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +9.1% ·
aandelenstroom +1.9% ·
netto nieuwe posities +8.3%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | +8 | 51.55M | $1.41B | +9 | −1 |
| Q1 2026 | 73 | -4 | 45.85M | $1.27B | +5 | −9 |
| Q4 2025 | 77 | 0 | 41.23M | $1.28B | — | — |
| Q3 2025 | 13 | -2 | 16.25M | $498.26M | — | −2 |
| Q2 2025 | 12 | +1 | 18.14M | $374.87M | +1 | — |
| Q1 2025 | 9 | 0 | 13.96M | $273.33M | — | — |
| Q4 2024 | 9 | 0 | 8.94M | $186.52M | +1 | −1 |
| Q3 2024 | 9 | -1 | 7.29M | $175.79M | — | −1 |
| Q2 2024 | 10 | — | 6.88M | $172.85M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 3.57M | -19.4% | $73.74M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 3.57M | -19.4% | $73.74M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 3 | Arrowstreet Capital ✦ | 3.45M | +152.2% | $71.37M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 3.17M | — | $65.41M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 3.17M | — | $65.41M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 3.17M | — | $65.41M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 3.17M | — | $65.41M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 3.17M | — | $65.41M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Renaissance Technologies ✦ | 2.77M | +22.3% | $57.16M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 10 | Marshall Wace ✦ | 1.91M | -12.6% | $39.40M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | Marshall Wace ✦ | 1.91M | -12.6% | $39.40M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 12 | Marshall Wace ✦ | 1.91M | -12.6% | $39.40M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 1.62M | -14.8% | $33.44M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 680.53K | — | $14.06M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 680.53K | — | $14.06M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 680.53K | — | $14.06M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Point72 Asset Management ✦ | 538.50K | -41.7% | $11.13M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Millennium Management ✦ | 386.30K | -55.5% | $7.98M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 29.96K | Nieuw | $619,028 | 0.0% | New | 1 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 29.96K | Nieuw | $619,028 | 0.0% | New | 1 | SEC ↗ |
| 21 | Geode Capital Management ✦ (passief) | 27.13K | +0.4% | $560,443 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | Baillie Gifford ✦ | 12 | -77.8% | $248 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| AQR Capital Management | $619,028 | 0.0% |
| AQR Capital Management | $619,028 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 25.36K aandelen, $6.69M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.